L. Dousset

1.3k total citations
34 papers, 618 citations indexed

About

L. Dousset is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, L. Dousset has authored 34 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Dermatology. Recurrent topics in L. Dousset's work include Cancer Immunotherapy and Biomarkers (10 papers), Cancer and Skin Lesions (6 papers) and Nonmelanoma Skin Cancer Studies (6 papers). L. Dousset is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Cancer and Skin Lesions (6 papers) and Nonmelanoma Skin Cancer Studies (6 papers). L. Dousset collaborates with scholars based in France, Australia and Spain. L. Dousset's co-authors include S. Prey, Caroline Dutriaux, Alain Taı̈eb, M. Beylot‐Barry, Anne Pham‐Ledard, Julien Sénéschal, Katia Boniface, Hamid Rezvani, Thomas Barnetche and Marie Kostine and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Free Radical Biology and Medicine and Annals of Oncology.

In The Last Decade

L. Dousset

30 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Dousset France 11 344 205 108 107 89 34 618
Mikio Masuzawa Japan 16 272 0.8× 246 1.2× 64 0.6× 81 0.8× 24 0.3× 47 697
Sébastien de Feraudy United States 13 174 0.5× 277 1.4× 76 0.7× 98 0.9× 18 0.2× 32 655
Karline Guilloteau France 8 172 0.5× 202 1.0× 315 2.9× 176 1.6× 65 0.7× 10 618
Jinchul Kim South Korea 10 234 0.7× 243 1.2× 175 1.6× 69 0.6× 22 0.2× 31 633
Julie Parmentier United States 8 165 0.5× 85 0.4× 136 1.3× 120 1.1× 124 1.4× 18 598
Sarah Maria Rudman United Kingdom 9 194 0.6× 169 0.8× 186 1.7× 69 0.6× 21 0.2× 21 541
Hirotsugu Hino Japan 13 86 0.3× 198 1.0× 53 0.5× 40 0.4× 105 1.2× 42 552
Annalisa Roberti Spain 9 138 0.4× 296 1.4× 78 0.7× 27 0.3× 44 0.5× 13 505
Victor Yazbeck United States 12 165 0.5× 220 1.1× 55 0.5× 20 0.2× 60 0.7× 34 472
E. Ken Parkinson United Kingdom 8 251 0.7× 421 2.1× 87 0.8× 21 0.2× 19 0.2× 8 744

Countries citing papers authored by L. Dousset

Since Specialization
Citations

This map shows the geographic impact of L. Dousset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Dousset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Dousset more than expected).

Fields of papers citing papers by L. Dousset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Dousset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Dousset. The network helps show where L. Dousset may publish in the future.

Co-authorship network of co-authors of L. Dousset

This figure shows the co-authorship network connecting the top 25 collaborators of L. Dousset. A scholar is included among the top collaborators of L. Dousset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Dousset. L. Dousset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dousset, L., Benjamin Dartigues, Walid Mahfouf, et al.. (2025). Metabolism-based scoring of cutaneous squamous cell carcinoma to predict tumour features and responses to treatment with dihydroorotate dehydrogenase inhibitors. British Journal of Dermatology. 193(5). 936–947.
2.
Dousset, L., Stéphane Bouchet, Célèste Lebbé, et al.. (2024). Tyrosine kinase inhibitors in cancers: Treatment optimization – Part I. Critical Reviews in Oncology/Hematology. 199. 104384–104384. 3 indexed citations
3.
Dousset, L., Célèste Lebbé, Joseph Ciccolini, et al.. (2024). Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II. Critical Reviews in Oncology/Hematology. 200. 104385–104385. 5 indexed citations
4.
Dousset, L., Walid Mahfouf, Corinne Faucheux, et al.. (2024). Energy metabolism rewiring following acute UVB irradiation is largely dependent on nuclear DNA damage. Free Radical Biology and Medicine. 227. 459–471. 4 indexed citations
5.
Caumont, Charline, L. Dousset, M. Beylot‐Barry, et al.. (2023). Assessment of Liquid Biopsy in Primary Cutaneous Diffuse Large B-Cell Lymphoma–Leg Type. Journal of Investigative Dermatology. 143(7). 1326–1329.e5. 2 indexed citations
6.
Battistella, Maxime, J.-M. Amici, L. Dousset, et al.. (2021). Clinicopathologic analysis of trichoblastoma and comparison with nodular basal cell carcinoma. Annales de Dermatologie et de Vénéréologie. 148(3). 177–182. 4 indexed citations
7.
Dousset, L., S. Prey, Caroline Dutriaux, et al.. (2021). Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective Study. Journal of Oncology. 2021. 1–8. 15 indexed citations
8.
Dousset, L., M. Beylot‐Barry, P. Celérier, et al.. (2021). Predictive Factors of Non-Response to Vismodegib in Locally Advanced Basal-Cell Carcinoma. Dermatology. 237(6). 1023–1028. 6 indexed citations
9.
Dousset, L., Thomas Barnetche, Marie Kostine, et al.. (2021). Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study. JAAD International. 5. 112–120. 15 indexed citations
10.
Dousset, L., C. Mertens, E. Gérard, et al.. (2020). Impact sur la qualité de vie et l’autonomie des patients de plus de 75 ans traités par anti-PD-1 pour un mélanome métastatique : étude prospective monocentrique. Annales de Dermatologie et de Vénéréologie. 147(11). 713–720. 1 indexed citations
11.
Hosseini, Mohsen, L. Dousset, Walid Mahfouf, et al.. (2019). UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis. Oncogenesis. 8(10). 52–52. 23 indexed citations
12.
Dousset, L., Katia Boniface, & Julien Sénéschal. (2019). Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies. Giornale Italiano di Dermatologia e Venereologia. 154(4). 435–443. 5 indexed citations
13.
Mahfouf, Walid, Mohsen Hosseini, Martin Serrano-Sanchez, et al.. (2019). Loss of Epidermal HIF-1α Blocks UVB-Induced Tumorigenesis by Affecting DNA Repair Capacity and Oxidative Stress. Journal of Investigative Dermatology. 139(9). 2016–2028.e7. 16 indexed citations
14.
Dousset, L., et al.. (2018). Long-lasting cutaneous tuberculosis owing to Mycobacterium bovis masquerading as sarcoidosis. JAAD Case Reports. 5(1). 1–4. 1 indexed citations
15.
Kostine, Marie, L. Rouxel, Thomas Barnetche, et al.. (2017). Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study. Annals of the Rheumatic Diseases. 77(3). 393–398. 208 indexed citations
16.
Raad, Houssam, Martin Serrano-Sanchez, Walid Mahfouf, et al.. (2017). NADPH Oxidase-1 Plays a Key Role in Keratinocyte Responses to UV Radiation and UVB-Induced Skin Carcinogenesis. Journal of Investigative Dermatology. 137(6). 1311–1321. 52 indexed citations
17.
Dousset, L., J.-M. Amici, B. Cribier, et al.. (2017). Étude prospective multicentrique de 2710 carcinomes basocellulaires : concordance entre agressivité clinique supposée et agressivité histologique. Annales de Dermatologie et de Vénéréologie. 144(12). S117–S118. 1 indexed citations
18.
Rousset, Marine, Caroline Dutriaux, Pauline Bosco‐Lévy, et al.. (2017). Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma. Clinica Chimica Acta. 472. 26–29. 28 indexed citations
19.
Jacquemin, C., Jérôme Rambert, Denis Thiolat, et al.. (2017). Vitiligo-like lesions occurring in patients receiving anti-programmed cell death–1 therapies are clinically and biologically distinct from vitiligo. Journal of the American Academy of Dermatology. 76(5). 863–870. 112 indexed citations
20.
Dousset, L., Julien Sénéschal, Katia Boniface, et al.. (2015). A Th2 Cytokine Interleukin-31 Signature in a Case of Sporadic Lichen Amyloidosis. Acta Dermato Venereologica. 95(2). 223–224. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026